可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Keith IM.The role of endogenous lung neuropeptides in regulation of the pulmonary circulation[J].Physiol Res,2000,49(5):519-537.
[2]Chen YF.Atrial natriuretic peptide in hypoxia[J].Peptides,2005,26(6):1068-1077.
[3]Welsh DJ,Peacock AJ.Cellular responses to hypoxia in the pulmonary circulation[J].High Alt Med Biol,2013,14(2):111-116.
[4]Tual L,Morel OE,Favret F,et al.Carvedilol inhibits right ventricular hypertrophy induced by chronic hypobaric hypoxia[J].Pflugers Arch,2006,452(4):371-379.
[5]Tuchscherer HA,Vanderpool RR,Chesler NC.Pulmonary vascular remodeling in isolated mouse lungs: effects on pulsatile pressure-flow relationships[J].J Biomech,2007,40(5):993-1001.
[6]Potter LR,Yoder AR,Flora DR,et al.Natriuretic peptides:their structures,receptors,physiologic functions and therapeutic applications[J].Handb Exp Pharmacol,2009(191):341-366.
[7]Chen BY,Chen JK,Zhu MZ,et al.AC-NP:a novel chimeric peptide with natriuretic and vasorelaxing actions[J].PLoS One,2011,6(5):e20477.
[8]Yu J,Feng HS,Chen BY,et al.Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats[J].Clin Exp Pharmacol Physiol,2010,37(1):69-74.
[9]Fujita S,Shimojo N,Terasaki F,et al.Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1/endothelin receptor A cascade[J].Heart Vessels,2013,28(5):646-657.